[
    {
        "drugresponse_id": "277276",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "42-MG-BA",
        "VALUE": "8.36",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1798",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277277",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "8-MG-BA",
        "VALUE": "8.15",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1052",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277280",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "T98G",
        "VALUE": "8.09",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0556",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277281",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "U-118-MG",
        "VALUE": "8.13",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0633",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277320",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "VA-ES-BJ",
        "VALUE": "8.34",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1785",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Epithelioid Sarcoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277348",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "TE-5",
        "VALUE": "8.15",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1764",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277378",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "HCE-4",
        "VALUE": "8.43",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1271",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277417",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "KELLY",
        "VALUE": "8.23",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_2092",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277436",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "MCF7",
        "VALUE": "8.09",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0031",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Invasive Ductal Carcinoma Not Otherwise Specified",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277471",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "SF539",
        "VALUE": "8.19",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1691",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Gliosarcoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277532",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "GAMG",
        "VALUE": "8.05",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1226",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277534",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "GI-1",
        "VALUE": "8.2",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1231",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Gliosarcoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277535",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "GI-ME-N",
        "VALUE": "8.35",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1232",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277540",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "H4",
        "VALUE": "8.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1239",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277545",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "HCC1806",
        "VALUE": "8.98",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1258",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Squamous Cell Breast Carcinoma Acantholytic Variant",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277557",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "HT-1080",
        "VALUE": "8.41",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0317",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Fibrosarcoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277593",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "G-402",
        "VALUE": "8.34",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1221",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Epithelioid Cell Type Gastrointestinal Stromal Tumor",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277602",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "KYSE-270",
        "VALUE": "8.36",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1350",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277604",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "KYSE-510",
        "VALUE": "8.85",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1354",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277641",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "MOG-G-UVW",
        "VALUE": "8.57",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_2614",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Anaplastic Astrocytoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277652",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "NB69",
        "VALUE": "8.06",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1448",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277660",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "NMC-G1",
        "VALUE": "8.15",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1608",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277713",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "SJRH30",
        "VALUE": "8.42",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0041",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Alveolar Rhabdomyosarcoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277717",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "SK-LMS-1",
        "VALUE": "8.58",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0628",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Vulvar Leiomyosarcoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277741",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "SW1783",
        "VALUE": "8.31",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1722",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Anaplastic Astrocytoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277746",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "SW872",
        "VALUE": "8.28",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1730",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Liposarcoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277749",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "SW982",
        "VALUE": "8.25",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1734",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Synovial Sarcoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277803",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "A204",
        "VALUE": "8.32",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1058",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Embryonal Rhabdomyosarcoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277825",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "CAL-51",
        "VALUE": "8.44",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1110",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Carcinoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277863",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "MFH-ino",
        "VALUE": "8.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1407",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Undifferentiated Pleomorphic Sarcoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277887",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "D-423MG",
        "VALUE": "8.08",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1160",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277894",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "M059J",
        "VALUE": "8.03",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0400",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277915",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "NB5",
        "VALUE": "8.24",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_8822",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277960",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "KYM-1",
        "VALUE": "8.68",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_3007",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Alveolar Rhabdomyosarcoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277961",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "KYSE-220",
        "VALUE": "8.17",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1359",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277962",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "LN-18",
        "VALUE": "8.03",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0392",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277963",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "LN-229",
        "VALUE": "8.19",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0393",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277964",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "LNZTA3WT4",
        "VALUE": "8.38",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_3540",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "278043",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "JIMT-1",
        "VALUE": "8.19",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_2077",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Carcinoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "380264",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "KELLY",
        "VALUE": "8.23",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_2092",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "380350",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "CHP-212",
        "VALUE": "8.01",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1125",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "380361",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "D-283MED",
        "VALUE": "8.41",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1155",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Medulloblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "380397",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "HCC1806",
        "VALUE": "8.54",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1258",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Squamous Cell Breast Carcinoma Acantholytic Variant",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "380458",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "KYSE-510",
        "VALUE": "8.41",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1354",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "380489",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "MHH-NB-11",
        "VALUE": "8.07",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1412",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277276",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "42-MG-BA",
        "VALUE": "8.36",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1798",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277277",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "8-MG-BA",
        "VALUE": "8.15",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1052",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277280",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "T98G",
        "VALUE": "8.09",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0556",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277281",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "U-118-MG",
        "VALUE": "8.13",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0633",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277320",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "VA-ES-BJ",
        "VALUE": "8.34",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1785",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Epithelioid Sarcoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277348",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "TE-5",
        "VALUE": "8.15",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1764",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277378",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "HCE-4",
        "VALUE": "8.43",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1271",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277417",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "KELLY",
        "VALUE": "8.23",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_2092",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277436",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "MCF7",
        "VALUE": "8.09",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0031",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Invasive Ductal Carcinoma Not Otherwise Specified",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277471",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "SF539",
        "VALUE": "8.19",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1691",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Gliosarcoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277532",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "GAMG",
        "VALUE": "8.05",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1226",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277534",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "GI-1",
        "VALUE": "8.2",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1231",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Gliosarcoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277535",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "GI-ME-N",
        "VALUE": "8.35",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1232",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277540",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "H4",
        "VALUE": "8.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1239",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277545",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "HCC1806",
        "VALUE": "8.98",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1258",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Squamous Cell Breast Carcinoma Acantholytic Variant",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277557",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "HT-1080",
        "VALUE": "8.41",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0317",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Fibrosarcoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277593",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "G-402",
        "VALUE": "8.34",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1221",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Epithelioid Cell Type Gastrointestinal Stromal Tumor",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277602",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "KYSE-270",
        "VALUE": "8.36",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1350",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277604",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "KYSE-510",
        "VALUE": "8.85",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1354",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277641",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "MOG-G-UVW",
        "VALUE": "8.57",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_2614",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Anaplastic Astrocytoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277652",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "NB69",
        "VALUE": "8.06",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1448",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277660",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "NMC-G1",
        "VALUE": "8.15",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1608",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277713",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "SJRH30",
        "VALUE": "8.42",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0041",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Alveolar Rhabdomyosarcoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277717",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "SK-LMS-1",
        "VALUE": "8.58",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0628",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Vulvar Leiomyosarcoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277741",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "SW1783",
        "VALUE": "8.31",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1722",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Anaplastic Astrocytoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277746",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "SW872",
        "VALUE": "8.28",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1730",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Liposarcoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277749",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "SW982",
        "VALUE": "8.25",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1734",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Synovial Sarcoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277803",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "A204",
        "VALUE": "8.32",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1058",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Embryonal Rhabdomyosarcoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277825",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "CAL-51",
        "VALUE": "8.44",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1110",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Carcinoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277863",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "MFH-ino",
        "VALUE": "8.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1407",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Undifferentiated Pleomorphic Sarcoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277887",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "D-423MG",
        "VALUE": "8.08",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1160",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277894",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "M059J",
        "VALUE": "8.03",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0400",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277915",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "NB5",
        "VALUE": "8.24",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_8822",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277960",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "KYM-1",
        "VALUE": "8.68",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_3007",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Alveolar Rhabdomyosarcoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277961",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "KYSE-220",
        "VALUE": "8.17",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1359",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277962",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "LN-18",
        "VALUE": "8.03",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0392",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277963",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "LN-229",
        "VALUE": "8.19",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0393",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277964",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "LNZTA3WT4",
        "VALUE": "8.38",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_3540",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "278043",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "JIMT-1",
        "VALUE": "8.19",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_2077",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Carcinoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "380264",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "KELLY",
        "VALUE": "8.23",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_2092",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "380350",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "CHP-212",
        "VALUE": "8.01",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1125",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "380361",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "D-283MED",
        "VALUE": "8.41",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1155",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Medulloblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "380397",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "HCC1806",
        "VALUE": "8.54",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1258",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Squamous Cell Breast Carcinoma Acantholytic Variant",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "380458",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "KYSE-510",
        "VALUE": "8.41",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1354",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "380489",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "MHH-NB-11",
        "VALUE": "8.07",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1412",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277276",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "42-MG-BA",
        "VALUE": "8.36",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1798",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277277",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "8-MG-BA",
        "VALUE": "8.15",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1052",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277280",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "T98G",
        "VALUE": "8.09",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0556",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277281",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "U-118-MG",
        "VALUE": "8.13",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0633",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277320",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "VA-ES-BJ",
        "VALUE": "8.34",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1785",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Epithelioid Sarcoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277348",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "TE-5",
        "VALUE": "8.15",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1764",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277378",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "HCE-4",
        "VALUE": "8.43",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1271",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277417",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "KELLY",
        "VALUE": "8.23",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_2092",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277436",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "MCF7",
        "VALUE": "8.09",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0031",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Invasive Ductal Carcinoma Not Otherwise Specified",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277471",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "SF539",
        "VALUE": "8.19",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1691",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Gliosarcoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277532",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "GAMG",
        "VALUE": "8.05",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1226",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277534",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "GI-1",
        "VALUE": "8.2",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1231",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Gliosarcoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277535",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "GI-ME-N",
        "VALUE": "8.35",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1232",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277540",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "H4",
        "VALUE": "8.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1239",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277545",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "HCC1806",
        "VALUE": "8.98",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1258",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Squamous Cell Breast Carcinoma Acantholytic Variant",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277557",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "HT-1080",
        "VALUE": "8.41",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0317",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Fibrosarcoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277593",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "G-402",
        "VALUE": "8.34",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1221",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Epithelioid Cell Type Gastrointestinal Stromal Tumor",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277602",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "KYSE-270",
        "VALUE": "8.36",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1350",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277604",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "KYSE-510",
        "VALUE": "8.85",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1354",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277641",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "MOG-G-UVW",
        "VALUE": "8.57",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_2614",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Anaplastic Astrocytoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277652",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "NB69",
        "VALUE": "8.06",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1448",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277660",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "NMC-G1",
        "VALUE": "8.15",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1608",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277713",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "SJRH30",
        "VALUE": "8.42",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0041",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Alveolar Rhabdomyosarcoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277717",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "SK-LMS-1",
        "VALUE": "8.58",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0628",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Vulvar Leiomyosarcoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277741",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "SW1783",
        "VALUE": "8.31",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1722",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Anaplastic Astrocytoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277746",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "SW872",
        "VALUE": "8.28",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1730",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Liposarcoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277749",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "SW982",
        "VALUE": "8.25",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1734",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Synovial Sarcoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277803",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "A204",
        "VALUE": "8.32",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1058",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Embryonal Rhabdomyosarcoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277825",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "CAL-51",
        "VALUE": "8.44",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1110",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Carcinoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277863",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "MFH-ino",
        "VALUE": "8.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1407",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Undifferentiated Pleomorphic Sarcoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277887",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "D-423MG",
        "VALUE": "8.08",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1160",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277894",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "M059J",
        "VALUE": "8.03",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0400",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277915",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "NB5",
        "VALUE": "8.24",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_8822",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277960",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "KYM-1",
        "VALUE": "8.68",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_3007",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Alveolar Rhabdomyosarcoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277961",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "KYSE-220",
        "VALUE": "8.17",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1359",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277962",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "LN-18",
        "VALUE": "8.03",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0392",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277963",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "LN-229",
        "VALUE": "8.19",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0393",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "277964",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "LNZTA3WT4",
        "VALUE": "8.38",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_3540",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "278043",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "JIMT-1",
        "VALUE": "8.19",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_2077",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Carcinoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "380264",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "KELLY",
        "VALUE": "8.23",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_2092",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "380350",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "CHP-212",
        "VALUE": "8.01",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1125",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "380361",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "D-283MED",
        "VALUE": "8.41",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1155",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Medulloblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "380397",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "HCC1806",
        "VALUE": "8.54",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1258",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Squamous Cell Breast Carcinoma Acantholytic Variant",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "380458",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "KYSE-510",
        "VALUE": "8.41",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1354",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "380489",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "MHH-NB-11",
        "VALUE": "8.07",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1412",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Anxiety",
        "Phase": "2"
    },
    {
        "drugresponse_id": "422",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "VA-ES-BJ",
        "VALUE": "9.0",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1785",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Epithelioid Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "463",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "TE-15",
        "VALUE": "8.7",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1763",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "484",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SF539",
        "VALUE": "9.35",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1691",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Gliosarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "522",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "KALS-1",
        "VALUE": "8.39",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1323",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "587",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "OCUB-M",
        "VALUE": "9.79",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1621",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Carcinoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "598",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SK-LMS-1",
        "VALUE": "8.6",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0628",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Vulvar Leiomyosarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "606",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SW872",
        "VALUE": "9.15",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1730",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Liposarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "666",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "TE-6",
        "VALUE": "8.5",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1765",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "699",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "KYM-1",
        "VALUE": "8.95",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_3007",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Alveolar Rhabdomyosarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "366071",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "H4",
        "VALUE": "8.33",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1239",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "366154",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "MDA-MB-453",
        "VALUE": "8.19",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0418",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Adenocarcinoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "366181",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "MRK-nu-1",
        "VALUE": "8.46",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1428",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Carcinoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "366185",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "NB69",
        "VALUE": "8.31",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1448",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "366273",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SW1088",
        "VALUE": "8.06",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1715",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "366332",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "AU565",
        "VALUE": "8.25",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1074",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Adenocarcinoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "366388",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "CAL-148",
        "VALUE": "8.43",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1106",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Carcinoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "366400",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "MDA-MB-415",
        "VALUE": "8.01",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0621",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Adenocarcinoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "366423",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "TE-6",
        "VALUE": "8.18",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1765",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "422",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "VA-ES-BJ",
        "VALUE": "9.0",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1785",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Epithelioid Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "463",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "TE-15",
        "VALUE": "8.7",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1763",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "484",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SF539",
        "VALUE": "9.35",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1691",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Gliosarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "522",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "KALS-1",
        "VALUE": "8.39",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1323",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "587",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "OCUB-M",
        "VALUE": "9.79",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1621",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Carcinoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "598",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SK-LMS-1",
        "VALUE": "8.6",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0628",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Vulvar Leiomyosarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "606",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SW872",
        "VALUE": "9.15",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1730",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Liposarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "666",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "TE-6",
        "VALUE": "8.5",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1765",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "699",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "KYM-1",
        "VALUE": "8.95",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_3007",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Alveolar Rhabdomyosarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "366071",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "H4",
        "VALUE": "8.33",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1239",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "366154",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "MDA-MB-453",
        "VALUE": "8.19",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0418",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Adenocarcinoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "366181",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "MRK-nu-1",
        "VALUE": "8.46",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1428",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Carcinoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "366185",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "NB69",
        "VALUE": "8.31",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1448",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "366273",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SW1088",
        "VALUE": "8.06",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1715",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "366332",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "AU565",
        "VALUE": "8.25",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1074",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Adenocarcinoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "366388",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "CAL-148",
        "VALUE": "8.43",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1106",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Carcinoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "366400",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "MDA-MB-415",
        "VALUE": "8.01",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0621",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Adenocarcinoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "366423",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "TE-6",
        "VALUE": "8.18",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1765",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "422",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "VA-ES-BJ",
        "VALUE": "9.0",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1785",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Epithelioid Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "463",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "TE-15",
        "VALUE": "8.7",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1763",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "484",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SF539",
        "VALUE": "9.35",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1691",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Gliosarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "522",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "KALS-1",
        "VALUE": "8.39",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1323",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "587",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "OCUB-M",
        "VALUE": "9.79",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1621",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Carcinoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "598",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SK-LMS-1",
        "VALUE": "8.6",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0628",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Vulvar Leiomyosarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "606",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SW872",
        "VALUE": "9.15",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1730",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Liposarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "666",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "TE-6",
        "VALUE": "8.5",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1765",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "699",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "KYM-1",
        "VALUE": "8.95",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_3007",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Alveolar Rhabdomyosarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "366071",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "H4",
        "VALUE": "8.33",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1239",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "366154",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "MDA-MB-453",
        "VALUE": "8.19",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0418",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Adenocarcinoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "366181",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "MRK-nu-1",
        "VALUE": "8.46",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1428",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Carcinoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "366185",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "NB69",
        "VALUE": "8.31",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1448",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "366273",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SW1088",
        "VALUE": "8.06",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1715",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "366332",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "AU565",
        "VALUE": "8.25",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1074",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Adenocarcinoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "366388",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "CAL-148",
        "VALUE": "8.43",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1106",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Carcinoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "366400",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "MDA-MB-415",
        "VALUE": "8.01",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0621",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Adenocarcinoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "366423",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "TE-6",
        "VALUE": "8.18",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1765",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "422",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "VA-ES-BJ",
        "VALUE": "9.0",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1785",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Epithelioid Sarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "463",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "TE-15",
        "VALUE": "8.7",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1763",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "484",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SF539",
        "VALUE": "9.35",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1691",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Gliosarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "522",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "KALS-1",
        "VALUE": "8.39",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1323",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "587",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "OCUB-M",
        "VALUE": "9.79",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1621",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Carcinoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "598",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SK-LMS-1",
        "VALUE": "8.6",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0628",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Vulvar Leiomyosarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "606",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SW872",
        "VALUE": "9.15",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1730",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Liposarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "666",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "TE-6",
        "VALUE": "8.5",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1765",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "699",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "KYM-1",
        "VALUE": "8.95",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_3007",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Alveolar Rhabdomyosarcoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "366071",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "H4",
        "VALUE": "8.33",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1239",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "366154",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "MDA-MB-453",
        "VALUE": "8.19",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0418",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Adenocarcinoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "366181",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "MRK-nu-1",
        "VALUE": "8.46",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1428",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Carcinoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "366185",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "NB69",
        "VALUE": "8.31",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1448",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "366273",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "SW1088",
        "VALUE": "8.06",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1715",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "366332",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "AU565",
        "VALUE": "8.25",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1074",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Adenocarcinoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "366388",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "CAL-148",
        "VALUE": "8.43",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1106",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Carcinoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "366400",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "MDA-MB-415",
        "VALUE": "8.01",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0621",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Adenocarcinoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "366423",
        "COMPOUND_NAME": "Rapamycin",
        "CELL_LINE_NAME": "TE-6",
        "VALUE": "8.18",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "60148419.0",
        "CHEMBL_ID": "CHEMBL413",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1765",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "QFJCIRLUMZQUOT-HPLJOQBZSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Behavior mechanisms",
        "Disease_name": "Mental Depression",
        "Phase": "2"
    },
    {
        "drugresponse_id": "401408",
        "COMPOUND_NAME": "Epirubicin",
        "CELL_LINE_NAME": "IMR-5",
        "VALUE": "8.01",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "65348.0",
        "CHEMBL_ID": "CHEMBL417",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1306",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "AOJJSUZBOXZQNB-VTZDEGQISA-N",
        "COMPOUND_CLASS": "GPCR inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thrombosis",
        "Phase": "3"
    },
    {
        "drugresponse_id": "401688",
        "COMPOUND_NAME": "Epirubicin",
        "CELL_LINE_NAME": "CHP-134",
        "VALUE": "8.02",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "65348.0",
        "CHEMBL_ID": "CHEMBL417",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1124",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "AOJJSUZBOXZQNB-VTZDEGQISA-N",
        "COMPOUND_CLASS": "GPCR inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thrombosis",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277276",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "42-MG-BA",
        "VALUE": "8.36",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1798",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277277",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "8-MG-BA",
        "VALUE": "8.15",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1052",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277280",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "T98G",
        "VALUE": "8.09",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0556",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277281",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "U-118-MG",
        "VALUE": "8.13",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0633",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277320",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "VA-ES-BJ",
        "VALUE": "8.34",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1785",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Epithelioid Sarcoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277348",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "TE-5",
        "VALUE": "8.15",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1764",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277378",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "HCE-4",
        "VALUE": "8.43",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1271",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277417",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "KELLY",
        "VALUE": "8.23",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_2092",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277436",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "MCF7",
        "VALUE": "8.09",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0031",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Invasive Ductal Carcinoma Not Otherwise Specified",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277471",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "SF539",
        "VALUE": "8.19",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1691",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Gliosarcoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277532",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "GAMG",
        "VALUE": "8.05",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1226",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277534",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "GI-1",
        "VALUE": "8.2",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1231",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Gliosarcoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277535",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "GI-ME-N",
        "VALUE": "8.35",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1232",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277540",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "H4",
        "VALUE": "8.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1239",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277545",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "HCC1806",
        "VALUE": "8.98",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1258",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Squamous Cell Breast Carcinoma Acantholytic Variant",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277557",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "HT-1080",
        "VALUE": "8.41",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0317",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Fibrosarcoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277593",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "G-402",
        "VALUE": "8.34",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1221",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Epithelioid Cell Type Gastrointestinal Stromal Tumor",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277602",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "KYSE-270",
        "VALUE": "8.36",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1350",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277604",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "KYSE-510",
        "VALUE": "8.85",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1354",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277641",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "MOG-G-UVW",
        "VALUE": "8.57",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_2614",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Anaplastic Astrocytoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277652",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "NB69",
        "VALUE": "8.06",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1448",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277660",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "NMC-G1",
        "VALUE": "8.15",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1608",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277713",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "SJRH30",
        "VALUE": "8.42",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0041",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Alveolar Rhabdomyosarcoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277717",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "SK-LMS-1",
        "VALUE": "8.58",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0628",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Vulvar Leiomyosarcoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277741",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "SW1783",
        "VALUE": "8.31",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1722",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Anaplastic Astrocytoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277746",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "SW872",
        "VALUE": "8.28",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1730",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Liposarcoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277749",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "SW982",
        "VALUE": "8.25",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1734",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Synovial Sarcoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277803",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "A204",
        "VALUE": "8.32",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1058",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Embryonal Rhabdomyosarcoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277825",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "CAL-51",
        "VALUE": "8.44",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1110",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Carcinoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277863",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "MFH-ino",
        "VALUE": "8.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1407",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Undifferentiated Pleomorphic Sarcoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277887",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "D-423MG",
        "VALUE": "8.08",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1160",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277894",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "M059J",
        "VALUE": "8.03",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0400",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277915",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "NB5",
        "VALUE": "8.24",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_8822",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277960",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "KYM-1",
        "VALUE": "8.68",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_3007",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Alveolar Rhabdomyosarcoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277961",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "KYSE-220",
        "VALUE": "8.17",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1359",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277962",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "LN-18",
        "VALUE": "8.03",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0392",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277963",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "LN-229",
        "VALUE": "8.19",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0393",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277964",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "LNZTA3WT4",
        "VALUE": "8.38",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_3540",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "278043",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "JIMT-1",
        "VALUE": "8.19",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_2077",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Carcinoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "380264",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "KELLY",
        "VALUE": "8.23",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_2092",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "380350",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "CHP-212",
        "VALUE": "8.01",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1125",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "380361",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "D-283MED",
        "VALUE": "8.41",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1155",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Medulloblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "380397",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "HCC1806",
        "VALUE": "8.54",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1258",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Squamous Cell Breast Carcinoma Acantholytic Variant",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "380458",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "KYSE-510",
        "VALUE": "8.41",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1354",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "380489",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "MHH-NB-11",
        "VALUE": "8.07",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1412",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277276",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "42-MG-BA",
        "VALUE": "8.36",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1798",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277277",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "8-MG-BA",
        "VALUE": "8.15",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1052",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277280",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "T98G",
        "VALUE": "8.09",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0556",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277281",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "U-118-MG",
        "VALUE": "8.13",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0633",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277320",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "VA-ES-BJ",
        "VALUE": "8.34",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1785",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Epithelioid Sarcoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277348",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "TE-5",
        "VALUE": "8.15",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1764",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277378",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "HCE-4",
        "VALUE": "8.43",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1271",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277417",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "KELLY",
        "VALUE": "8.23",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_2092",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277436",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "MCF7",
        "VALUE": "8.09",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0031",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Invasive Ductal Carcinoma Not Otherwise Specified",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277471",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "SF539",
        "VALUE": "8.19",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1691",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Gliosarcoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277532",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "GAMG",
        "VALUE": "8.05",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1226",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277534",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "GI-1",
        "VALUE": "8.2",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1231",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Gliosarcoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277535",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "GI-ME-N",
        "VALUE": "8.35",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1232",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277540",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "H4",
        "VALUE": "8.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1239",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277545",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "HCC1806",
        "VALUE": "8.98",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1258",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Squamous Cell Breast Carcinoma Acantholytic Variant",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277557",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "HT-1080",
        "VALUE": "8.41",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0317",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Fibrosarcoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277593",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "G-402",
        "VALUE": "8.34",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1221",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Epithelioid Cell Type Gastrointestinal Stromal Tumor",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277602",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "KYSE-270",
        "VALUE": "8.36",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1350",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277604",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "KYSE-510",
        "VALUE": "8.85",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1354",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277641",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "MOG-G-UVW",
        "VALUE": "8.57",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_2614",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Anaplastic Astrocytoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277652",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "NB69",
        "VALUE": "8.06",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1448",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277660",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "NMC-G1",
        "VALUE": "8.15",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1608",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277713",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "SJRH30",
        "VALUE": "8.42",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0041",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Alveolar Rhabdomyosarcoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277717",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "SK-LMS-1",
        "VALUE": "8.58",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0628",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Vulvar Leiomyosarcoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277741",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "SW1783",
        "VALUE": "8.31",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1722",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Anaplastic Astrocytoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277746",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "SW872",
        "VALUE": "8.28",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1730",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Liposarcoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277749",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "SW982",
        "VALUE": "8.25",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1734",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Synovial Sarcoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277803",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "A204",
        "VALUE": "8.32",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1058",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Embryonal Rhabdomyosarcoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277825",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "CAL-51",
        "VALUE": "8.44",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1110",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Carcinoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277863",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "MFH-ino",
        "VALUE": "8.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1407",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Undifferentiated Pleomorphic Sarcoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277887",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "D-423MG",
        "VALUE": "8.08",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1160",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277894",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "M059J",
        "VALUE": "8.03",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0400",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277915",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "NB5",
        "VALUE": "8.24",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_8822",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277960",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "KYM-1",
        "VALUE": "8.68",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_3007",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Alveolar Rhabdomyosarcoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277961",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "KYSE-220",
        "VALUE": "8.17",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1359",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277962",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "LN-18",
        "VALUE": "8.03",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0392",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277963",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "LN-229",
        "VALUE": "8.19",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0393",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277964",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "LNZTA3WT4",
        "VALUE": "8.38",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_3540",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "278043",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "JIMT-1",
        "VALUE": "8.19",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_2077",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Carcinoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "380264",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "KELLY",
        "VALUE": "8.23",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_2092",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "380350",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "CHP-212",
        "VALUE": "8.01",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1125",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "380361",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "D-283MED",
        "VALUE": "8.41",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1155",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Medulloblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "380397",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "HCC1806",
        "VALUE": "8.54",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1258",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Squamous Cell Breast Carcinoma Acantholytic Variant",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "380458",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "KYSE-510",
        "VALUE": "8.41",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1354",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "380489",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "MHH-NB-11",
        "VALUE": "8.07",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1412",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277276",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "42-MG-BA",
        "VALUE": "8.36",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1798",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277277",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "8-MG-BA",
        "VALUE": "8.15",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1052",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277280",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "T98G",
        "VALUE": "8.09",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0556",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277281",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "U-118-MG",
        "VALUE": "8.13",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0633",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277320",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "VA-ES-BJ",
        "VALUE": "8.34",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1785",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Epithelioid Sarcoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277348",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "TE-5",
        "VALUE": "8.15",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1764",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277378",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "HCE-4",
        "VALUE": "8.43",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1271",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277417",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "KELLY",
        "VALUE": "8.23",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_2092",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277436",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "MCF7",
        "VALUE": "8.09",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0031",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Invasive Ductal Carcinoma Not Otherwise Specified",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277471",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "SF539",
        "VALUE": "8.19",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1691",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Gliosarcoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277532",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "GAMG",
        "VALUE": "8.05",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1226",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277534",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "GI-1",
        "VALUE": "8.2",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1231",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Gliosarcoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277535",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "GI-ME-N",
        "VALUE": "8.35",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1232",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277540",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "H4",
        "VALUE": "8.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1239",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277545",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "HCC1806",
        "VALUE": "8.98",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1258",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Squamous Cell Breast Carcinoma Acantholytic Variant",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277557",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "HT-1080",
        "VALUE": "8.41",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0317",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Fibrosarcoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277593",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "G-402",
        "VALUE": "8.34",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1221",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Epithelioid Cell Type Gastrointestinal Stromal Tumor",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277602",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "KYSE-270",
        "VALUE": "8.36",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1350",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277604",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "KYSE-510",
        "VALUE": "8.85",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1354",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277641",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "MOG-G-UVW",
        "VALUE": "8.57",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_2614",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Anaplastic Astrocytoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277652",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "NB69",
        "VALUE": "8.06",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1448",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277660",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "NMC-G1",
        "VALUE": "8.15",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1608",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277713",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "SJRH30",
        "VALUE": "8.42",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0041",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Alveolar Rhabdomyosarcoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277717",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "SK-LMS-1",
        "VALUE": "8.58",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0628",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Vulvar Leiomyosarcoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277741",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "SW1783",
        "VALUE": "8.31",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1722",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Anaplastic Astrocytoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277746",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "SW872",
        "VALUE": "8.28",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1730",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Liposarcoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277749",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "SW982",
        "VALUE": "8.25",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1734",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Synovial Sarcoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277803",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "A204",
        "VALUE": "8.32",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1058",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Embryonal Rhabdomyosarcoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277825",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "CAL-51",
        "VALUE": "8.44",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1110",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Carcinoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277863",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "MFH-ino",
        "VALUE": "8.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1407",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Undifferentiated Pleomorphic Sarcoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277887",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "D-423MG",
        "VALUE": "8.08",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1160",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277894",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "M059J",
        "VALUE": "8.03",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0400",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277915",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "NB5",
        "VALUE": "8.24",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_8822",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277960",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "KYM-1",
        "VALUE": "8.68",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_3007",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Alveolar Rhabdomyosarcoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277961",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "KYSE-220",
        "VALUE": "8.17",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1359",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277962",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "LN-18",
        "VALUE": "8.03",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0392",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277963",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "LN-229",
        "VALUE": "8.19",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0393",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "277964",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "LNZTA3WT4",
        "VALUE": "8.38",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_3540",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "278043",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "JIMT-1",
        "VALUE": "8.19",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_2077",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Carcinoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "380264",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "KELLY",
        "VALUE": "8.23",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_2092",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "380350",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "CHP-212",
        "VALUE": "8.01",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1125",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "380361",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "D-283MED",
        "VALUE": "8.41",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1155",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Medulloblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "380397",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "HCC1806",
        "VALUE": "8.54",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1258",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Squamous Cell Breast Carcinoma Acantholytic Variant",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "380458",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "KYSE-510",
        "VALUE": "8.41",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1354",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "380489",
        "COMPOUND_NAME": "Gemcitabine",
        "CELL_LINE_NAME": "MHH-NB-11",
        "VALUE": "8.07",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "60750.0",
        "CHEMBL_ID": "CHEMBL888",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1412",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "SDUQYLNIPVEERB-QPPQHZFASA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Thromboembolism",
        "Phase": "3"
    },
    {
        "drugresponse_id": "1955",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "8-MG-BA",
        "VALUE": "8.26",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1052",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "1979",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "VA-ES-BJ",
        "VALUE": "8.53",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1785",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Epithelioid Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2001",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "HCE-4",
        "VALUE": "8.3",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1271",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2023",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "TE-15",
        "VALUE": "8.9",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1763",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2028",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "TE-1",
        "VALUE": "8.21",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1759",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2029",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "TE-10",
        "VALUE": "8.59",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1760",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2030",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "TE-8",
        "VALUE": "8.71",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1766",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2050",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SF268",
        "VALUE": "8.05",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1689",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2053",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "Becker",
        "VALUE": "8.04",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1093",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2078",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "GI-1",
        "VALUE": "8.49",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1231",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Gliosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2089",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "IMR-5",
        "VALUE": "8.4",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1306",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2096",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KALS-1",
        "VALUE": "8.48",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1323",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2149",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "no-10",
        "VALUE": "8.36",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_3075",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2166",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "OCUB-M",
        "VALUE": "8.5",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1621",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2180",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-LMS-1",
        "VALUE": "8.33",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0628",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Vulvar Leiomyosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2183",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-PN-DW",
        "VALUE": "8.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1703",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Primitive Neuroectodermal Tumor",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2191",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SW982",
        "VALUE": "8.07",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1734",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Synovial Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2251",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "MFH-ino",
        "VALUE": "8.56",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1407",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Undifferentiated Pleomorphic Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2254",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "TE-9",
        "VALUE": "8.31",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1767",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2255",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "TE-11",
        "VALUE": "8.86",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1761",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2256",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "TE-6",
        "VALUE": "8.19",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1765",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "363878",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "8-MG-BA",
        "VALUE": "8.18",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1052",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "363956",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "HCC1187",
        "VALUE": "8.07",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1247",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Ductal Breast Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "363960",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "HCC2157",
        "VALUE": "8.16",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1261",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Ductal Breast Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "363980",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EC-GI-10",
        "VALUE": "8.25",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1187",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "364024",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "TE-10",
        "VALUE": "8.39",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1760",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "364050",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "Hs-578-T",
        "VALUE": "8.54",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0332",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Invasive Ductal Carcinoma Not Otherwise Specified",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "364076",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SF539",
        "VALUE": "8.17",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1691",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Gliosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "364117",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "Daoy",
        "VALUE": "8.17",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1167",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Medulloblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "364118",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "D-283MED",
        "VALUE": "8.15",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1155",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Medulloblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "364177",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "IMR-5",
        "VALUE": "8.63",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1306",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "364213",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KYSE-180",
        "VALUE": "8.09",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1349",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "364254",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "MOG-G-UVW",
        "VALUE": "8.27",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_2614",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Anaplastic Astrocytoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "364260",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "MRK-nu-1",
        "VALUE": "8.42",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1428",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "364309",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "OCUB-M",
        "VALUE": "8.17",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1621",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "364345",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-PN-DW",
        "VALUE": "8.3",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1703",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Primitive Neuroectodermal Tumor",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "364415",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "AU565",
        "VALUE": "8.14",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1074",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Adenocarcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "364505",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "TE-11",
        "VALUE": "8.73",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1761",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "364513",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KP-N-YS",
        "VALUE": "8.1",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1342",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "364517",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "D-336MG",
        "VALUE": "8.12",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1156",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "364519",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "D-423MG",
        "VALUE": "8.14",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1160",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "364521",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "D-566MG",
        "VALUE": "8.43",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1166",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "364547",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB17",
        "VALUE": "8.37",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1445",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "364549",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB13",
        "VALUE": "8.17",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1443",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "364550",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB14",
        "VALUE": "8.42",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1444",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "364581",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "Hs-683",
        "VALUE": "8.41",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0844",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Oligodendroglioma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "364592",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KYM-1",
        "VALUE": "8.27",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_3007",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Alveolar Rhabdomyosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "364593",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KYSE-220",
        "VALUE": "8.06",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1359",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "364716",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "T-T",
        "VALUE": "8.24",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_3174",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "1955",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "8-MG-BA",
        "VALUE": "8.26",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1052",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "1979",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "VA-ES-BJ",
        "VALUE": "8.53",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1785",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Epithelioid Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2001",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "HCE-4",
        "VALUE": "8.3",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1271",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2023",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "TE-15",
        "VALUE": "8.9",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1763",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2028",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "TE-1",
        "VALUE": "8.21",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1759",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2029",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "TE-10",
        "VALUE": "8.59",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1760",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2030",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "TE-8",
        "VALUE": "8.71",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1766",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2050",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SF268",
        "VALUE": "8.05",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1689",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2053",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "Becker",
        "VALUE": "8.04",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1093",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2078",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "GI-1",
        "VALUE": "8.49",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1231",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Gliosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2089",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "IMR-5",
        "VALUE": "8.4",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1306",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2096",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KALS-1",
        "VALUE": "8.48",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1323",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2149",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "no-10",
        "VALUE": "8.36",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_3075",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2166",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "OCUB-M",
        "VALUE": "8.5",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1621",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2180",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-LMS-1",
        "VALUE": "8.33",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0628",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Vulvar Leiomyosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2183",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-PN-DW",
        "VALUE": "8.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1703",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Primitive Neuroectodermal Tumor",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2191",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SW982",
        "VALUE": "8.07",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1734",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Synovial Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2251",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "MFH-ino",
        "VALUE": "8.56",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1407",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Undifferentiated Pleomorphic Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2254",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "TE-9",
        "VALUE": "8.31",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1767",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2255",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "TE-11",
        "VALUE": "8.86",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1761",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2256",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "TE-6",
        "VALUE": "8.19",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1765",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "363878",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "8-MG-BA",
        "VALUE": "8.18",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1052",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "363956",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "HCC1187",
        "VALUE": "8.07",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1247",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Ductal Breast Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "363960",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "HCC2157",
        "VALUE": "8.16",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1261",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Ductal Breast Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "363980",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EC-GI-10",
        "VALUE": "8.25",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1187",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "364024",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "TE-10",
        "VALUE": "8.39",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1760",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "364050",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "Hs-578-T",
        "VALUE": "8.54",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0332",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Invasive Ductal Carcinoma Not Otherwise Specified",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "364076",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SF539",
        "VALUE": "8.17",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1691",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Gliosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "364117",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "Daoy",
        "VALUE": "8.17",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1167",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Medulloblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "364118",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "D-283MED",
        "VALUE": "8.15",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1155",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Medulloblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "364177",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "IMR-5",
        "VALUE": "8.63",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1306",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "364213",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KYSE-180",
        "VALUE": "8.09",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1349",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "364254",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "MOG-G-UVW",
        "VALUE": "8.27",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_2614",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Anaplastic Astrocytoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "364260",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "MRK-nu-1",
        "VALUE": "8.42",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1428",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "364309",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "OCUB-M",
        "VALUE": "8.17",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1621",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "364345",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-PN-DW",
        "VALUE": "8.3",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1703",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Primitive Neuroectodermal Tumor",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "364415",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "AU565",
        "VALUE": "8.14",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1074",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Adenocarcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "364505",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "TE-11",
        "VALUE": "8.73",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1761",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "364513",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KP-N-YS",
        "VALUE": "8.1",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1342",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "364517",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "D-336MG",
        "VALUE": "8.12",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1156",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "364519",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "D-423MG",
        "VALUE": "8.14",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1160",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "364521",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "D-566MG",
        "VALUE": "8.43",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1166",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "364547",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB17",
        "VALUE": "8.37",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1445",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "364549",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB13",
        "VALUE": "8.17",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1443",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "364550",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB14",
        "VALUE": "8.42",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1444",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "364581",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "Hs-683",
        "VALUE": "8.41",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0844",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Oligodendroglioma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "364592",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KYM-1",
        "VALUE": "8.27",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_3007",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Alveolar Rhabdomyosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "364593",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KYSE-220",
        "VALUE": "8.06",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1359",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "364716",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "T-T",
        "VALUE": "8.24",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_3174",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "1955",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "8-MG-BA",
        "VALUE": "8.26",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1052",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "1979",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "VA-ES-BJ",
        "VALUE": "8.53",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1785",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Epithelioid Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2001",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "HCE-4",
        "VALUE": "8.3",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1271",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2023",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "TE-15",
        "VALUE": "8.9",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1763",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2028",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "TE-1",
        "VALUE": "8.21",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1759",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2029",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "TE-10",
        "VALUE": "8.59",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1760",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2030",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "TE-8",
        "VALUE": "8.71",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1766",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2050",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SF268",
        "VALUE": "8.05",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1689",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2053",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "Becker",
        "VALUE": "8.04",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1093",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2078",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "GI-1",
        "VALUE": "8.49",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1231",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Gliosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2089",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "IMR-5",
        "VALUE": "8.4",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1306",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2096",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KALS-1",
        "VALUE": "8.48",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1323",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2149",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "no-10",
        "VALUE": "8.36",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_3075",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2166",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "OCUB-M",
        "VALUE": "8.5",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1621",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2180",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-LMS-1",
        "VALUE": "8.33",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0628",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Vulvar Leiomyosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2183",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-PN-DW",
        "VALUE": "8.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1703",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Primitive Neuroectodermal Tumor",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2191",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SW982",
        "VALUE": "8.07",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1734",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Synovial Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2251",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "MFH-ino",
        "VALUE": "8.56",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1407",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Undifferentiated Pleomorphic Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2254",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "TE-9",
        "VALUE": "8.31",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1767",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2255",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "TE-11",
        "VALUE": "8.86",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1761",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "2256",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "TE-6",
        "VALUE": "8.19",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1765",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "363878",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "8-MG-BA",
        "VALUE": "8.18",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1052",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "363956",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "HCC1187",
        "VALUE": "8.07",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1247",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Ductal Breast Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "363960",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "HCC2157",
        "VALUE": "8.16",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1261",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Ductal Breast Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "363980",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EC-GI-10",
        "VALUE": "8.25",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1187",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "364024",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "TE-10",
        "VALUE": "8.39",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1760",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "364050",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "Hs-578-T",
        "VALUE": "8.54",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0332",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Invasive Ductal Carcinoma Not Otherwise Specified",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "364076",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SF539",
        "VALUE": "8.17",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1691",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Gliosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "364117",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "Daoy",
        "VALUE": "8.17",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1167",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Medulloblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "364118",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "D-283MED",
        "VALUE": "8.15",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1155",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Medulloblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "364177",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "IMR-5",
        "VALUE": "8.63",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1306",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "364213",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KYSE-180",
        "VALUE": "8.09",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1349",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "364254",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "MOG-G-UVW",
        "VALUE": "8.27",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_2614",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Anaplastic Astrocytoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "364260",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "MRK-nu-1",
        "VALUE": "8.42",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1428",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "364309",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "OCUB-M",
        "VALUE": "8.17",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1621",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "364345",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-PN-DW",
        "VALUE": "8.3",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1703",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Primitive Neuroectodermal Tumor",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "364415",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "AU565",
        "VALUE": "8.14",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1074",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Adenocarcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "364505",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "TE-11",
        "VALUE": "8.73",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1761",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "364513",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KP-N-YS",
        "VALUE": "8.1",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1342",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "364517",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "D-336MG",
        "VALUE": "8.12",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1156",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "364519",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "D-423MG",
        "VALUE": "8.14",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1160",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "364521",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "D-566MG",
        "VALUE": "8.43",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1166",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "364547",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB17",
        "VALUE": "8.37",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1445",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "364549",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB13",
        "VALUE": "8.17",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1443",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "364550",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB14",
        "VALUE": "8.42",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1444",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "364581",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "Hs-683",
        "VALUE": "8.41",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0844",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Oligodendroglioma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "364592",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KYM-1",
        "VALUE": "8.27",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_3007",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Alveolar Rhabdomyosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "364593",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KYSE-220",
        "VALUE": "8.06",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1359",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "364716",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "T-T",
        "VALUE": "8.24",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_3174",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Arterial Occlusive Diseases",
        "Phase": "2"
    },
    {
        "drugresponse_id": "1955",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "8-MG-BA",
        "VALUE": "8.26",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1052",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "1979",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "VA-ES-BJ",
        "VALUE": "8.53",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1785",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Epithelioid Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2001",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "HCE-4",
        "VALUE": "8.3",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1271",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2023",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "TE-15",
        "VALUE": "8.9",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1763",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2028",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "TE-1",
        "VALUE": "8.21",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1759",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2029",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "TE-10",
        "VALUE": "8.59",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1760",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2030",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "TE-8",
        "VALUE": "8.71",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1766",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2050",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SF268",
        "VALUE": "8.05",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1689",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2053",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "Becker",
        "VALUE": "8.04",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1093",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2078",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "GI-1",
        "VALUE": "8.49",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1231",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Gliosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2089",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "IMR-5",
        "VALUE": "8.4",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1306",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2096",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KALS-1",
        "VALUE": "8.48",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1323",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2149",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "no-10",
        "VALUE": "8.36",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_3075",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2166",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "OCUB-M",
        "VALUE": "8.5",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1621",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2180",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-LMS-1",
        "VALUE": "8.33",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0628",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Vulvar Leiomyosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2183",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-PN-DW",
        "VALUE": "8.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1703",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Primitive Neuroectodermal Tumor",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2191",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SW982",
        "VALUE": "8.07",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1734",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Synovial Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2251",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "MFH-ino",
        "VALUE": "8.56",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1407",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Undifferentiated Pleomorphic Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2254",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "TE-9",
        "VALUE": "8.31",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1767",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2255",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "TE-11",
        "VALUE": "8.86",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1761",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2256",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "TE-6",
        "VALUE": "8.19",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1765",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "363878",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "8-MG-BA",
        "VALUE": "8.18",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1052",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "363956",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "HCC1187",
        "VALUE": "8.07",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1247",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Ductal Breast Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "363960",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "HCC2157",
        "VALUE": "8.16",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1261",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Ductal Breast Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "363980",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EC-GI-10",
        "VALUE": "8.25",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1187",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "364024",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "TE-10",
        "VALUE": "8.39",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1760",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "364050",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "Hs-578-T",
        "VALUE": "8.54",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0332",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Invasive Ductal Carcinoma Not Otherwise Specified",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "364076",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SF539",
        "VALUE": "8.17",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1691",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Gliosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "364117",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "Daoy",
        "VALUE": "8.17",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1167",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Medulloblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "364118",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "D-283MED",
        "VALUE": "8.15",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1155",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Medulloblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "364177",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "IMR-5",
        "VALUE": "8.63",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1306",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "364213",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KYSE-180",
        "VALUE": "8.09",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1349",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "364254",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "MOG-G-UVW",
        "VALUE": "8.27",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_2614",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Anaplastic Astrocytoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "364260",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "MRK-nu-1",
        "VALUE": "8.42",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1428",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "364309",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "OCUB-M",
        "VALUE": "8.17",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1621",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "364345",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-PN-DW",
        "VALUE": "8.3",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1703",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Primitive Neuroectodermal Tumor",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "364415",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "AU565",
        "VALUE": "8.14",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1074",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Adenocarcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "364505",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "TE-11",
        "VALUE": "8.73",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1761",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "364513",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KP-N-YS",
        "VALUE": "8.1",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1342",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "364517",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "D-336MG",
        "VALUE": "8.12",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1156",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "364519",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "D-423MG",
        "VALUE": "8.14",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1160",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "364521",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "D-566MG",
        "VALUE": "8.43",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1166",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "364547",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB17",
        "VALUE": "8.37",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1445",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "364549",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB13",
        "VALUE": "8.17",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1443",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "364550",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB14",
        "VALUE": "8.42",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1444",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "364581",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "Hs-683",
        "VALUE": "8.41",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0844",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Oligodendroglioma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "364592",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KYM-1",
        "VALUE": "8.27",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_3007",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Alveolar Rhabdomyosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "364593",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KYSE-220",
        "VALUE": "8.06",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1359",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "364716",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "T-T",
        "VALUE": "8.24",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_3174",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "1955",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "8-MG-BA",
        "VALUE": "8.26",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1052",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "1979",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "VA-ES-BJ",
        "VALUE": "8.53",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1785",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Epithelioid Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2001",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "HCE-4",
        "VALUE": "8.3",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1271",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2023",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "TE-15",
        "VALUE": "8.9",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1763",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2028",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "TE-1",
        "VALUE": "8.21",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1759",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2029",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "TE-10",
        "VALUE": "8.59",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1760",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2030",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "TE-8",
        "VALUE": "8.71",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1766",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2050",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SF268",
        "VALUE": "8.05",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1689",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2053",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "Becker",
        "VALUE": "8.04",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1093",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2078",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "GI-1",
        "VALUE": "8.49",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1231",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Gliosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2089",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "IMR-5",
        "VALUE": "8.4",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1306",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2096",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KALS-1",
        "VALUE": "8.48",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1323",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2149",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "no-10",
        "VALUE": "8.36",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_3075",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2166",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "OCUB-M",
        "VALUE": "8.5",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1621",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2180",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-LMS-1",
        "VALUE": "8.33",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0628",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Vulvar Leiomyosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2183",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-PN-DW",
        "VALUE": "8.11",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1703",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Primitive Neuroectodermal Tumor",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2191",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SW982",
        "VALUE": "8.07",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1734",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Synovial Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2251",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "MFH-ino",
        "VALUE": "8.56",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1407",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Undifferentiated Pleomorphic Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2254",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "TE-9",
        "VALUE": "8.31",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1767",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2255",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "TE-11",
        "VALUE": "8.86",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1761",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2256",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "TE-6",
        "VALUE": "8.19",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1765",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "363878",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "8-MG-BA",
        "VALUE": "8.18",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1052",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "363956",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "HCC1187",
        "VALUE": "8.07",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1247",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Ductal Breast Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "363960",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "HCC2157",
        "VALUE": "8.16",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1261",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Ductal Breast Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "363980",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "EC-GI-10",
        "VALUE": "8.25",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1187",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "364024",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "TE-10",
        "VALUE": "8.39",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1760",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "364050",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "Hs-578-T",
        "VALUE": "8.54",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0332",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Invasive Ductal Carcinoma Not Otherwise Specified",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "364076",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SF539",
        "VALUE": "8.17",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1691",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Gliosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "364117",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "Daoy",
        "VALUE": "8.17",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1167",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Medulloblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "364118",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "D-283MED",
        "VALUE": "8.15",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1155",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Medulloblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "364177",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "IMR-5",
        "VALUE": "8.63",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1306",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "364213",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KYSE-180",
        "VALUE": "8.09",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1349",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "364254",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "MOG-G-UVW",
        "VALUE": "8.27",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_2614",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Anaplastic Astrocytoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "364260",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "MRK-nu-1",
        "VALUE": "8.42",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1428",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "364309",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "OCUB-M",
        "VALUE": "8.17",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1621",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "364345",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SK-PN-DW",
        "VALUE": "8.3",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1703",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Primitive Neuroectodermal Tumor",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "364415",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "AU565",
        "VALUE": "8.14",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1074",
        "ONCOTREE_LINEAGE": "Breast",
        "ONCOTREE_PRIMARY_DISEASE": "Breast Adenocarcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "364505",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "TE-11",
        "VALUE": "8.73",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1761",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "364513",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KP-N-YS",
        "VALUE": "8.1",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1342",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "364517",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "D-336MG",
        "VALUE": "8.12",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1156",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "364519",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "D-423MG",
        "VALUE": "8.14",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1160",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "364521",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "D-566MG",
        "VALUE": "8.43",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1166",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "364547",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB17",
        "VALUE": "8.37",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1445",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "364549",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB13",
        "VALUE": "8.17",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1443",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "364550",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "NB14",
        "VALUE": "8.42",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1444",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "364581",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "Hs-683",
        "VALUE": "8.41",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_0844",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Oligodendroglioma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "364592",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KYM-1",
        "VALUE": "8.27",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_3007",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Alveolar Rhabdomyosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "364593",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "KYSE-220",
        "VALUE": "8.06",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1359",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "364716",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "T-T",
        "VALUE": "8.24",
        "METRIC": "pIC50",
        "DATASET": "GDSC2",
        "Pubmed_ID": "27397505",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_3174",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "1955",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "8-MG-BA",
        "VALUE": "8.26",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1052",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Glioblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "1979",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "VA-ES-BJ",
        "VALUE": "8.53",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1785",
        "ONCOTREE_LINEAGE": "Soft Tissue",
        "ONCOTREE_PRIMARY_DISEASE": "Epithelioid Sarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2001",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "HCE-4",
        "VALUE": "8.3",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1271",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2023",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "TE-15",
        "VALUE": "8.9",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1763",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2028",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "TE-1",
        "VALUE": "8.21",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1759",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2029",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "TE-10",
        "VALUE": "8.59",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1760",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2030",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "TE-8",
        "VALUE": "8.71",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1766",
        "ONCOTREE_LINEAGE": "Esophagus",
        "ONCOTREE_PRIMARY_DISEASE": "Esophageal Squamous Cell Carcinoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2050",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "SF268",
        "VALUE": "8.05",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1689",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2053",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "Becker",
        "VALUE": "8.04",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1093",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Astrocytoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2078",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "GI-1",
        "VALUE": "8.49",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1231",
        "ONCOTREE_LINEAGE": "Central Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Gliosarcoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    },
    {
        "drugresponse_id": "2089",
        "COMPOUND_NAME": "Paclitaxel",
        "CELL_LINE_NAME": "IMR-5",
        "VALUE": "8.4",
        "METRIC": "pIC50",
        "DATASET": "GDSC1",
        "Pubmed_ID": "22460902 | 23180760",
        "PUBCHEM_ID": "441276.0",
        "CHEMBL_ID": "CHEMBL428647",
        "MAX_PHASE": "Approved",
        "RRID": "CVCL_1306",
        "ONCOTREE_LINEAGE": "Peripheral Nervous System",
        "ONCOTREE_PRIMARY_DISEASE": "Neuroblastoma",
        "INCHI_KEY": "RCINICONZNJXQF-MZXODVADSA-N",
        "COMPOUND_CLASS": "Transporter inhibitors",
        "Disease_class": "Cardiovascular",
        "Disease_name": "Coronary Restenosis",
        "Phase": "1"
    }
]